Thomas R Cimato1, Alexis Conway2, Julianne Nichols1, Paul K Wallace2. 1. Department of Medicine/Division of Cardiology, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York. 2. Departments of Flow and Image Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Abstract
BACKGROUND: Circulating hematopoietic progenitors (HPCs) are involved in inflammatory diseases such as atherosclerosis, the immune response to cancer, and disorders of the hematopoietic system. HPC characterization by flow cytometry typically utilizes CD34 in combination with other cell surface markers to identify cell populations that give rise to specific hematopoietic lineages. CD133, also known as prominin-1, is a cell surface protein found in HPCs that has a similar but not interchangeable expression pattern with CD34 for characterization of HPC populations. Our goal was to determine the distribution of CD133 expression within HPC sub-types amongst circulating CD34+ cells. METHODS: The quantity of different HPC populations within the CD34+ CD133+ and CD34+ CD133- fractions of venous blood obtained from healthy human subjects was measured using multicolor flow cytometry. RESULTS: The majority of circulating CD34+ cells is CD133-. CD133+ CD34+ cells express low levels of CD38, contain cell populations bearing cell surface markers of hematopoietic stem cells, multipotent progenitors, and multilymphoid progenitors, and are largely devoid of CD38 expressing lineage specified progenitors. These findings clarify the composition of circulating CD133+ CD34+ cell types in adult human subjects.
BACKGROUND: Circulating hematopoietic progenitors (HPCs) are involved in inflammatory diseases such as atherosclerosis, the immune response to cancer, and disorders of the hematopoietic system. HPC characterization by flow cytometry typically utilizes CD34 in combination with other cell surface markers to identify cell populations that give rise to specific hematopoietic lineages. CD133, also known as prominin-1, is a cell surface protein found in HPCs that has a similar but not interchangeable expression pattern with CD34 for characterization of HPC populations. Our goal was to determine the distribution of CD133 expression within HPC sub-types amongst circulating CD34+ cells. METHODS: The quantity of different HPC populations within the CD34+ CD133+ and CD34+ CD133- fractions of venous blood obtained from healthy human subjects was measured using multicolor flow cytometry. RESULTS: The majority of circulating CD34+ cells is CD133-. CD133+ CD34+ cells express low levels of CD38, contain cell populations bearing cell surface markers of hematopoietic stem cells, multipotent progenitors, and multilymphoid progenitors, and are largely devoid of CD38 expressing lineage specified progenitors. These findings clarify the composition of circulating CD133+ CD34+ cell types in adult human subjects.
Authors: Ibhar Al Mheid; Salim S Hayek; Yi-An Ko; Faysal Akbik; Qunna Li; Nima Ghasemzadeh; Greg S Martin; Qi Long; Muhammad Hammadah; A Maziar Zafari; Viola Vaccarino; Edmund K Waller; Arshed A Quyyumi Journal: Circ Res Date: 2016-07-19 Impact factor: 17.367
Authors: U M Gehling; S Ergün; U Schumacher; C Wagener; K Pantel; M Otte; G Schuch; P Schafhausen; T Mende; N Kilic; K Kluge; B Schäfer; D K Hossfeld; W Fiedler Journal: Blood Date: 2000-05-15 Impact factor: 22.113
Authors: Thomas J Povsic; Richard Sloane; Jennifer B Green; Jiying Zhou; Carl F Pieper; Megan P Pearson; Eric D Peterson; Harvey J Cohen; Miriam C Morey Journal: J Diabetes Complications Date: 2013-09-19 Impact factor: 2.852
Authors: Gian Paolo Fadini; Mauro Rigato; Roberta Cappellari; Benedetta Maria Bonora; Angelo Avogaro Journal: Diabetes Care Date: 2016-11-04 Impact factor: 19.112
Authors: Wendy W Pang; Elizabeth A Price; Debashis Sahoo; Isabel Beerman; William J Maloney; Derrick J Rossi; Stanley L Schrier; Irving L Weissman Journal: Proc Natl Acad Sci U S A Date: 2011-11-28 Impact factor: 11.205
Authors: Min Hu; Shaowei Li; Siddharth Menon; Bo Liu; Michael S Hu; Michael T Longaker; H Peter Lorenz Journal: Stem Cells Transl Med Date: 2016-04-13 Impact factor: 6.940
Authors: Radosław Kurzelowski; Kamil Barański; Guido Caluori; Wojciech Szot; Krzysztof Grabowski; Aleksandra Michalewska-Włudarczyk; Marcin Syzdół; Wacław Kuczmik; Anna Błach; Beata Ochała; Damian Hudziak; Jacek Wilczek; Krzysztof S Gołba; Zdenek Starek; Michał Tendera; Wojciech Wojakowski; Tomasz Jadczyk Journal: Postepy Kardiol Interwencyjnej Date: 2021-09-14 Impact factor: 1.426